What is the recommended oral treatment regimen for Clostridioides difficile (C. diff) with vancomycin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Oral Treatment of Clostridioides difficile Infection with Vancomycin

For initial episodes of C. difficile infection, oral vancomycin should be administered at a dose of 125 mg four times daily for 10 days. 1

Treatment Based on Disease Severity

Non-severe C. difficile Infection

  • Metronidazole 500 mg orally three times daily for 10 days is an option for non-severe cases where access to vancomycin is limited 2, 3
  • Vancomycin 125 mg orally four times daily for 10 days is recommended if metronidazole cannot be used or is not preferred 2
  • Low-dose vancomycin (125 mg four times daily) is as effective as high-dose vancomycin (500 mg four times daily) for non-severe cases 4

Severe C. difficile Infection

  • Vancomycin 125 mg orally four times daily for 10 days is the first-line treatment 2
  • Severe CDI is defined by leukocytosis (WBC >15,000 cells/mL), serum creatinine >1.5 mg/dL, or albumin <30 g/L 2, 3
  • No significant difference in outcomes has been demonstrated between low-dose (125 mg four times daily) and high-dose (500 mg four times daily) vancomycin for severe CDI 5, 6

Fulminant C. difficile Infection

  • Vancomycin 500 mg orally four times daily is recommended 2
  • If ileus is present, add rectal vancomycin 500 mg in 100 mL normal saline every 6 hours as a retention enema 2
  • Intravenous metronidazole 500 mg every 8 hours should be administered together with oral or rectal vancomycin, particularly if ileus is present 2

Treatment of Recurrent C. difficile Infection

First Recurrence

  • Treat as an initial episode based on severity assessment 2
  • If metronidazole was used for the initial episode, switch to vancomycin 125 mg four times daily for 10 days 2, 3

Second and Subsequent Recurrences

  • Vancomycin 125 mg four times daily for at least 10 days 2
  • Consider a tapered and pulsed vancomycin regimen after the initial course: 2
    • Vancomycin 125 mg four times daily for 10-14 days, then
    • Vancomycin 125 mg twice daily for 7 days, then
    • Vancomycin 125 mg once daily for 7 days, then
    • Vancomycin 125 mg every 2-3 days for 2-8 weeks 2

Important Clinical Considerations

  • Discontinue the inciting antibiotic as soon as possible, as continued use significantly increases risk of recurrence 2
  • Avoid antiperistaltic agents and opiates as they may mask symptoms and worsen disease 2, 3
  • For patients unable to take oral medications, consider vancomycin 500 mg via nasogastric tube four times daily 2
  • Recent research suggests that pulse dosing of vancomycin may not effectively clear C. difficile spores, though it remains a recommended clinical practice for recurrent infections 7, 2
  • Monitor renal function in patients over 65 years of age, as nephrotoxicity can occur following oral vancomycin therapy 1

Pitfalls to Avoid

  • Do not use parenteral vancomycin for C. difficile infection as it is not effective for intestinal infections 1, 2
  • Avoid prolonged courses of metronidazole due to risk of cumulative and potentially irreversible neurotoxicity 2
  • Do not delay treatment initiation in severe or fulminant cases while awaiting laboratory confirmation 2
  • Remember that hand hygiene with soap and water (not alcohol-based sanitizers) is necessary to prevent transmission, as alcohol does not kill C. difficile spores 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.